Skip to main content
Equibles
LUCD logo

LUCD

Lucid Diagnostics Inc.
$1.00 +0.01 (+1.01%) At close · Jul 10
Market Cap
$203.07M
Shares
203,066,783

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$1.00 Open$0.99 Day$0.97–1.01 52W$0.90–1.63 Avg vol 30d1.5M Short int9.4M · 4.6% float · 3.6d Short vol69% Last earningsMay 14, 2026 DataOct 2021–Jul 2026 Filing10-Q · May 13
Up next
Next earnings call
Aug 13, 2026 Est · unconfirmed · in 5 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed May 13, 2026
AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Equibles Rating blended score · not investment advice
      Overall
      Sell
      SellHoldBuy
      Technical Sell Momentum Very Weak Sentiment Bullish Fundamentals Strong Quant / Vol Very High
      Market backdrop VIX 15 · calm Equity put/call 0.55
      Technical
      price trend
      Sell
      50 / 200-day cross No cross
      Price vs 200-day avg −13%
      below
      Price vs 50-day avg −3%
      below
      RSI (14) 46
      neutral
      MACD trend Negative
      52-week position 14%
      near low
      Volume (OBV) Bullish div.
      accumulating
      Momentum
      relative strength
      Very Weak
      1-month return −3%
      trailing
      6-month return −20%
      trailing
      YTD return −8%
      this year
      Relative strength −29%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bullish
      Trend (MA cross) No cross
      50d $1 › 200d $1 — 200d above 50d
      Institutional flow Accumulating
      2 of 102 funds reported for Jun 30 · net +54.6K sh shares · +1 new
      Insider flow Accumulating
      Net +$245.3K over 90 days · 0% sells
      Short interest Rising
      4.64% of float · ▲ +26.8% MoM · 3.6 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      102 holders — near 3-yr high, broad support
      Squeeze score 52
      elevated · 0–100
      Fundamentals
      Strong
      Revenue growth +79%
      Y/Y
      Gross margin 9%
      contracting
      EPS growth +17%
      Y/Y
      Free cash flow $-46.7M
      Balance sheet $22.4M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 63%
      annualized · 1-yr
      Max drawdown −36%
      past year
      ATR 5.4%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Technicals

      trend & momentum for long-term holders Sell
      3 · 3 · 1
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −13% Bearish
      Price vs 50-day avg
      −3% Neutral
      RSI (14)
      46 Neutral
      MACD trend
      Negative Bearish
      52-week position
      14% Bearish
      Volume (OBV)
      Bullish div. Bullish
      Market signals — smart money & positioning
      Bullish · 3 of 6
      Trend (MA cross) No cross
      50d $1 › 200d $1 — 200d above 50d
      Institutional flow Accumulating
      2 of 102 funds reported for Jun 30 · net +54.6K sh shares · +1 new
      Insider flow Accumulating
      Net +$245.3K over 90 days · 0% sells
      Short interest Rising
      4.64% of float · ▲ +26.8% MoM · 3.6 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      102 holders — near 3-yr high, broad support
      Price context
      position in its 52-week range
      52-wk low $1 Now $1 · 14% 52-wk high $2
      vs 200-day avg -13% vs 50-day avg -3%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from its earnings releases, calls, and filings
      Metric Latest Period YoY
      Proforma cash $45M 1Q26 —

      Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

      Versus peers

      Medical Devices — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      LUCD
      Lucid Diagnostics Inc.
      this stock
      		$203.07M -8.3% +544.0% — 4.6%
      ABT
      Abbott Laboratories
      		 $163.42B -24.3% +5.7% 26.3 1.3%
      SYK
      Stryker Corp
      		 $126.42B -6.7% +11.2% 38.2 1.8%
      MDT
      Medtronic plc
      		 $107.36B -13.5% +8.4% 22.5 1.5%
      BSX
      Boston Scientific Corp
      		 $66.54B -52.8% +5.5% 18.7 1.9%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      103
      % held
      17.3%
      Reported
      2 of 102
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      77
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      9.4M
      Days to cover
      3.6d
      Change
      +2.0M sh
      View
      Short Volume
      Short vol %
      69%
      As of
      Jul 10, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      1.7K
      Value
      $1.7K
      As of
      Jun 12, 2026
      View
      Off-Exchange
      Off-exchange %
      68.9%
      Week of
      May 4, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net buying
      Net (90d)
      +$245.3K
      Buyers / Sellers
      1 / 0
      Buyers Sellers
      View
      Financials
      Financials
      Revenue (FY)
      $4.3M
      Net income (FY)
      $-58.0M
      EPS diluted
      $-1.05
      View
      Filings
      SEC Filings
      Latest
      Investor Event Transcript
      Filed
      Jun 30, 2026
      This year
      9
      View
      Proposed Sales
      Value
      $49.1K
      Shares
      33.9K
      Filed
      Sep 26, 2023
      View
      Exempt Offerings
      Offering
      $22.0M
      Filed
      Dec 6, 2024
      View
      Earnings & Events
      Earnings Calls
      Last call
      May 14, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      LUCD -6.5% -2.9% -20.0% -6.5% -8.3%
      SPY +0.8% +2.0% +8.9% +0.7% +10.2%
      vs SPY -7.3% -4.9% -28.9% -7.2% -18.5%
      Key facts CIK 1799011 CUSIP 54948X109 13F (30d) 2 filings 2 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)